Shaers of NeoGenomics, Inc. (NASDAQ:NEO) have been recommended as a long term growth pick. - With- the firm’s stock- price currently trading around $16.40, the firm has proven a solid track record of growth over the recent years. - Investors might consider the stock as a long term growth candidate as the firm has yielded- 26.47% earnings per share growth over the past 5 years and- 34.00% revenue growth over that same time frame.-



Investors may be searching high and low for the secret to attaining success in the markets. Knowing when to sell can be just as important as deciding which stocks to buy. Holding on to a loser for too long may leave a sour taste in the mouth. Investors may have unrealistic expectations about a particular name. Knowing when to cut and run can be a gigantic savior for overall portfolio health. Of course if investors end up selling winners too early, they will most likely be leaving too much profit on the table. Finding a good balance and knowing overall market conditions can help with the decision if the time has come. Closely tracking fundamentals and technicals can help give some insight into stock price behavior. Making sure company earnings are in line may also be a wise choice when investing in a recently researched stock.


Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time. - A -ldquo;buy-and-hold-rdquo; investor will consider long-term growth as a longer time period then a day trader will. The buy-and-hold strategy looks ahead farther into the future, giving short-term price swings less consideration as long as the fundamentals stay the same. -


Let’s take a look at how the stock has been performing recently.- Over the past twelve months, NeoGenomics, Inc. (NASDAQ:NEO)’s stock was 30.06%.- Over the last week of the month, it was -1.32%, -7.40% over the last quarter, and- 17.23% for the past six months.-


Over the past 50 days, NeoGenomics, Inc.’s stock- is- -4.26% off of the high and 48.42% removed from the low.- Their 52-Week High and Low are as follows:- -13.87% (High), 131.64%, (Low).-


Despite the past success, investors want to know where the stock is headed from here. - Analysts covering the shares have a consensus short-term price target of $19.88 on the equity. - Analysts have a consensus recommendation of 1.40 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.- -


As we move into the second half of the year, investors will be keeping a close watch on their portfolios. There are plenty of financial gurus who are predicting the end of the bull market run, and there are plenty on the other side who believe that stocks are bound for greater heights. Whichever way the markets go, investors will need to watch which companies are hitting their marks on the earnings front. Investors may closely follow sell-side analyst estimates. It is important to remember that analyst projections are just that, projections. Following analyst expectations can provide a good glimpse into company actions, but strictly following what the analysts are saying may lead to difficulty in the future. Doing careful and extensive individual stock research may provide the investor with a more robust scope with which to successfully trade the market.






Full article